Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALVO

Alvotech

Mar 20 • 04:00PM ET

3.53

-0.05 -1.40 %

Healthcare • Drug Manufacturers - Specialty & Generic • Luxembourg • NASD

Peers: ABBV PFE MRK LLY AMGN BIIB VRTX GILD REGN BMY

| Held by: IBB IDNA PRFZ IBBQ GLCR BIB

Scroll to Statements

Index	-	P/E	15.33	EPS (ttm)	0.23	Insider Own	65.71%	Shs Outstand	301.81M	Perf Week	1.73%
Market Cap	1.17B	Forward P/E	12.80	EPS next Y	0.28	Insider Trans	0.00%	Shs Float	113.26M	Perf Month	-18.29%
Enterprise Value	2.41B	PEG	-	EPS next Q	-0.03	Inst Own	4.93%	Short Float	2.61%	Perf Quarter	-29.40%
Income	69.50M	P/S	2.04	EPS this Y	189.88%	Inst Trans	-1.05%	Short Ratio	5.80	Perf Half Y	-54.86%
Sales	570.95M	P/B	-	EPS next Y	206.83%	ROA	5.26%	Short Interest	2.96M	Perf YTD	-31.19%
Book/sh	-0.59	P/C	27.21	EPS next 5Y	-	ROE	-	52W High	11.85 -70.21%	Perf Year	-69.44%
Cash/sh	0.13	P/FCF	-	EPS past 3/5Y	- -30.68%	ROIC	6.62%	52W Low	3.42 3.21%	Perf 3Y	-73.72%
Dividend Est.	-	EV/EBITDA	31.39	Sales past 3/5Y	- -	Gross Margin	55.41%	Volatility	5.39% 5.62%	Perf 5Y	-65.56%
Dividend TTM	-	EV/Sales	4.21	EPS Y/Y TTM	113.87%	Oper. Margin	7.19%	ATR (14)	0.24	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.74	Sales Y/Y TTM	55.38%	Profit Margin	12.17%	RSI (14)	33.79	Recom	2.20
Dividend Gr. 3/5Y	- -	Current Ratio	1.42	EPS Q/Q	53.97%	SMA20	-8.75%	Beta	0.22	Target Price	7.06
Payout	-	Debt/Eq	-	Sales Q/Q	10.55%	SMA50	-21.99%	Rel Volume	2.47	Prev Close	3.58
Employees	1032	LT Debt/Eq	-	Earnings	Mar 18 AMC	SMA200	-48.47%	Avg Volume	510.95K	Price	3.53
IPO	Nov 09, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	-5417.24% 6.79%	Trades		Volume	1,261,633	Change	-1.40%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-09-25	Initiated	Barclays	Underweight	$5
Nov-04-25	Downgrade	Deutsche Bank	Buy → Hold	$8
Oct-14-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$14
Sep-23-25	Upgrade	Deutsche Bank	Hold → Buy	$14
Feb-14-25	Initiated	UBS	Buy	$18
Jan-29-24	Upgrade	Barclays	Equal Weight → Overweight	$10 → $17
Oct-20-23	Upgrade	Citigroup	Sell → Neutral	$5 → $10
Sep-21-23	Initiated	Barclays	Equal Weight	$10
Sep-07-22	Initiated	Morgan Stanley	Equal-Weight	$10
Sep-06-22	Downgrade	Citigroup	Buy → Sell	$12 → $5
Jul-26-22	Initiated	Citigroup	Buy	$12

Show Previous Ratings

Mar-18-26 06:15PM	Alvotech Q4 2025 and Full Year 2025 Financial Results (GlobeNewswire) -5.79%
09:18AM	Alvotech (ALVO) Q4 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Mar-17-26 09:18AM	Alvotech (ALVO) Q4 2025 Earnings Report Preview: What To Expect (GuruFocus.com) +5.82%
Mar-04-26 03:00AM	Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Feb-26-26 04:00PM	Transactions of Managers and Closely Associated Persons (GlobeNewswire)
04:08AM	Loading…
Feb-15-26 04:08AM	Alvotech (ALVO) Announces Strong Results for Clinical Trial for AVT80 (Insider Monkey)
Feb-11-26 11:00AM	Alvotech Announces Increase in Number of Own Shares (GlobeNewswire) -6.73%
Feb-05-26 03:00AM	Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio (GlobeNewswire)
Feb-04-26 01:39PM	Alvotech (ALVO): A Bull Case Theory (Insider Monkey)
Feb-02-26 03:00AM	Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates (GlobeNewswire)
Jan-29-26 03:00AM	Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea 2mg (GlobeNewswire)
Jan-22-26 09:26AM	Dr. Reddy's Q3 Earnings Match Estimates, Revenues Rise Y/Y (Zacks)
Jan-16-26 08:52AM	ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now? (Zacks)
Jan-09-26 03:16AM	Alvotech (ALVO) Secures $100 Million in New Financing (Insider Monkey)
Jan-07-26 05:00PM	Correction: Transactions of Managers and Closely Associated Persons (GlobeNewswire)
03:00PM	Loading…
Jan-06-26 03:00PM	Transactions of Managers and Closely Associated Persons (GlobeNewswire) -6.53%
07:15AM	Alvotech announces planned CEO succession and leadership transition (GlobeNewswire)
Dec-31-25 04:30PM	Alvotech Secures Term Loan Facility of USD 100 Million (GlobeNewswire)
Dec-29-25 02:40PM	Changes in company's own shares (GlobeNewswire) -5.51%
Dec-22-25 03:26PM	Alvotech's Financial Calendar for 2026 (GlobeNewswire)
02:00AM	Alvotech announces European launch of first-in-market biosimilar to Simponi (golimumab) globally by partner Advanz Pharma (GlobeNewswire)
Dec-21-25 09:03AM	Alvotech (ALVO): Firm Reaffirms 2025 Growth Outlook (Insider Monkey)
Dec-19-25 03:30AM	Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea (GlobeNewswire)
Dec-17-25 02:30AM	Alvotech Successfully Places USD 108 Million Senior Unsecured Convertible Bonds in a Significantly Oversubscribed Offering (GlobeNewswire)
Dec-16-25 11:48AM	Alvotech Launches $100 Million Senior Unsecured Convertible Bond Offering to Continue Strong Investment in R&D, Support Manufacturing, Global Product Launches and Enhance Liquidity Position, reaffirms 2025 outlook and provides 2026 guidance (GlobeNewswire) -6.67%
Dec-11-25 09:30AM	Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman (PR Newswire)
Dec-05-25 05:06AM	New Strong Sell Stocks for Dec.5 (Zacks) +7.89%
Dec-04-25 01:39PM	Alvotech (ALVO): A Bull Case Theory (Insider Monkey) +9.27%
Dec-02-25 08:10PM	Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman (PR Newswire)
Nov-28-25 03:59AM	New Strong Sell Stocks for Nov. 28 (Zacks)
08:01PM	Loading…
Nov-24-25 08:01PM	Alvotech (ALVO) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Regulatory Challenges (GuruFocus.com) +6.42%
05:30AM	Alvotech Announces Approval of AVT03, a Biosimilar to Prolia and Xgeva (denosumab) in the European Economic Area (GlobeNewswire)
Nov-21-25 05:27AM	New Strong Sell Stocks for Nov. 21st (Zacks)
05:10AM	Alvotech and Advanz announce EC approval for Gobivaz biosimilar (Pharmaceutical Business Review)
Nov-20-25 04:00AM	Alvotech and Advanz Pharma Receive Marketing Approval Across the European Economic Area for Gobivaz, a First-in-Market Biosimilar to Simponi (golimumab) (GlobeNewswire)
Nov-13-25 09:06AM	Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman (PR Newswire)
04:59AM	New Strong Sell Stocks for Nov. 13 (Zacks)
Nov-12-25 05:55PM	Alvotech (ALVO) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:40PM	Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update (GlobeNewswire)
07:20AM	Earnings To Watch: Alvotech (ALVO) Reports Q3 2025 Result (GuruFocus.com)
Nov-11-25 07:23AM	Alvotech (ALVO) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-10-25 04:00AM	UK High Court Rules in Favor of Alvotech Paving Way for Manufacture and Market Entry of AVT06, biosimilar to Eylea (aflibercept) (GlobeNewswire)
Nov-07-25 08:10AM	Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates (Zacks) +12.85%
05:20AM	Alvotech and Advanz announce MHRA marketing authorisations for Gobivaz (Pharmaceutical Business Review)
Nov-06-25 09:07AM	Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz, a Biosimilar to Simponi (golimumab), from the MHRA (GlobeNewswire)
08:30AM	Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-05-25 10:00AM	Analysts Estimate Alvotech (ALVO) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:15AM	X4 Pharmaceuticals (XFOR) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
Nov-04-25 04:01PM	Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update (GlobeNewswire)
02:00AM	Alvotech faces FDA setback for its Simponi biosimilar AVT05 (Pharmaceutical Technology)
Nov-02-25 05:12PM	Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05 (GlobeNewswire)
Oct-27-25 11:32AM	Dr. Reddy's Q2 Earnings Beat Estimates, Generics Sales Boost Revenues (Zacks)
Oct-22-25 05:00AM	Alvotech Announces Changes in Global Business Development and Commercial Operations Team (GlobeNewswire)
Oct-21-25 03:53AM	Strength Seen in Cartesian Therapeutics, Inc. (RNAC): Can Its 8.2% Jump Turn into More Strength? (Zacks)
Oct-15-25 09:55AM	Wall Street Analysts See a 105.88% Upside in Alvotech (ALVO): Can the Stock Really Move This High? (Zacks) +5.65%
Oct-09-25 10:19AM	Voyager Therapeutics (VYGR) Soars 11.6%: Is Further Upside Left in the Stock? (Zacks)
Oct-06-25 08:00AM	Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR (omalizumab) (Business Wire)
04:40AM	European Marketing Application for AVT23, a Proposed Biosimilar to Xolair (omalizumab), Accepted by the European Medicines Agency (GlobeNewswire)
Sep-30-25 09:15AM	Here's How Alvotech is Expanding its Portfolio Beyond Immunology (Zacks)
Sep-24-25 03:42AM	Alvotech (ALVO) Surges 8.6%: Is This an Indication of Further Gains? (Zacks)
Sep-23-25 12:19PM	Alvotech vs. Teva Pharma: Which Generic Drugmaker is the Better Play? (Zacks) +8.61%
Sep-22-25 06:15AM	European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech's Proposed Biosimilar to Prolia and Xgeva (GlobeNewswire)
04:30AM	European Medicines Agency Recommends Marketing Approval of Gobivaz, Alvotech's Proposed Biosimilar to Simponi (golimumab) with Advanz Pharma as Commercialization Partner (GlobeNewswire)
Sep-19-25 07:45AM	Alvotech Announces Marketing Approval in Japan of Three New Biosimilars (GlobeNewswire)
Sep-18-25 09:33AM	Here's How ALVO's Commercial Partnerships Are Driving Top-line Growth (Zacks)
Sep-09-25 09:09AM	ALVO Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell? (Zacks)
Sep-04-25 09:15AM	Alvotech Meets Investors and Participates in a Fireside Chat at the Morgan Stanley 23rd Annual Global Healthcare Conference in New York (GlobeNewswire)
Aug-21-25 04:30AM	Advanz Pharma and Alvotech receive European approval for Mynzepli, Biosimilar to Eylea (GlobeNewswire)
Aug-20-25 06:05AM	Alvotech appoints Patrik Ling as VP of Investor Relations Scandinavia (GlobeNewswire) -5.41%
Aug-14-25 11:41AM	Kodiak Q2 Loss Wider Than Expected, Pipeline Development in Focus (Zacks) -5.41%
Aug-13-25 05:40PM	Alvotech (ALVO) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:15PM	Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update (GlobeNewswire)
09:55AM	Wall Street Analysts Think Alvotech (ALVO) Could Surge 102.31%: Read This Before Placing a Bet (Zacks)
Aug-12-25 03:00PM	ADC Therapeutics SA (ADCT) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
10:26AM	Immunovant's Q1 Loss Narrower Than Expected, Pipeline in Focus (Zacks)
10:16AM	Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus (Zacks)
Aug-06-25 05:15PM	Travere Therapeutics (TVTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT (GlobeNewswire)
Jul-30-25 10:11AM	Alvotech Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
Jul-24-25 11:21AM	Dr. Reddy's Q1 Earnings Beat Estimates, Generics Sales Boost Revenues (Zacks)
09:55AM	Wall Street Analysts See a 91.05% Upside in Alvotech (ALVO): Can the Stock Really Move This High? (Zacks)
Jul-17-25 09:35AM	Down 6.6% in 4 Weeks, Here's Why You Should You Buy the Dip in Alvotech (ALVO) (Zacks)
Jul-16-25 09:39AM	Alvotech (ALVO) Announces Acquisition of Ivers-Lee Group (Insider Monkey)
Jul-10-25 04:40AM	Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer (GlobeNewswire)
04:40AM	Alvotech Appoints Linda Jonsdottir as Chief Financial Officer (GlobeNewswire)
Jul-09-25 08:59AM	Alvotech expands biosimilars capabilities with Ivers-Lee acquisition (Packaging Gateway)
04:30AM	Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee in Switzerland (GlobeNewswire)
04:30AM	Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in Switzerland (GlobeNewswire)
Jul-06-25 04:15AM	Alvotech (ALVO) Announces a Commercialization Agreement With Advanz Pharma (Insider Monkey)
Jul-03-25 07:02PM	Notification for the purposes of article 13 of the Luxembourg law of 11 January 2008 on transparency requirements for issuers (GlobeNewswire)
Jul-01-25 07:54PM	Granting of Stock Options and Vesting of Restricted Share Units (GlobeNewswire)
04:00AM	Alvotech and Advanz Pharma Enter into European Supply and Commercialization Agreement for Biosimilar Candidate to Cimzia (certolizumab pegol) (GlobeNewswire)
Jun-26-25 10:25AM	Alvotech, Kashiv, Advanz announce study of AVT23 met primary endpoint (TipRanks)
04:15AM	Alvotech's Lenders Lower Interest on Senior Secured Term Loan Facility (GlobeNewswire)
Jun-25-25 04:45PM	Main Results of 2025 Annual and Extraordinary General Meeting (GlobeNewswire)
04:00AM	Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair (omalizumab) (GlobeNewswire)
Jun-24-25 09:05AM	Alvotech (ALVO): A Bull Case Theory (Insider Monkey)
Jun-23-25 04:00AM	European Medicines Agency Recommends Market Approval of AVT06, Alvotech's Proposed Biosimilar to Eylea (aflibercept) (GlobeNewswire)
Jun-11-25 04:20PM	Alvotech's Private Placement Completed with Delivery of SDRs and Shares to Investors (GlobeNewswire)
Jun-09-25 09:55AM	Wall Street Analysts Think Alvotech (ALVO) Could Surge 72.61%: Read This Before Placing a Bet (Zacks)

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Robert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ALVO

Alvotech

Upgrade your FINVIZ experience